Skip to content
DataLookout
Menu

NCT05503251

Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases

StatusCompleted
PhasePhase 2
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 6 words
    • Trial completed
    • Primary completion date changed from estimate of Jun 28, 2026 to Jun 30, 2025
  2. Notable Primary and study completion dates pushed to Jun 28, 2026v6
  3. Notable Phase: Not applicable to Phase 2
    • Primary completion date: Apr 28, 2025 to Oct 28, 2025
    • Study completion date: Aug 30, 2025 to Dec 31, 2025
    v5
  4. Minor Trial status: Recruiting to Active, Not Recruitingv4 Show 4 more changesShow less
    • Enrollment target: estimated 47 to confirmed 110
    • Primary completion date: Dec 31, 2024 to Apr 28, 2025
    • Study completion date: Dec 31, 2025 to Aug 30, 2025
    • Site details revised
  5. Notable Phase: Phase 2 to Not applicable
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 31, 2022 to Aug 30, 2022
    • Site details revised
    v3
  6. Notable Eligibility criteria shortened, about 3 wordsv2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Quality of life (QOL)
Timeframe: Up to 12 months after radiation therapy

Arms and interventions

Arm I (neuropsychological evaluation)Experimental

Patients undergo neuropsychological evaluations with a certified neuropsychologist at baseline, 3 months, and 6 months.

Arm II (usual care)Active comparator

Patients receive usual care.

Other: Best Practice, Quality-of-Life Assessment, Questionnaire Administration

Behavioral: Neuropsychological Assessment

Sites

1 site in 1 country

  • Ohio State University Comprehensive Cancer CenterColumbus, Ohio, United States